نتایج جستجو برای: myc

تعداد نتایج: 16295  

Journal: :Cancer research 1990
A Rosolen L Whitesell N Ikegaki R H Kennett L M Neckers

The N-myc gene is transiently expressed during normal embryonic development and abnormally expressed in several tumors of neuroendocrine origin. Little is known of the function of the N-myc gene product in either normal or neoplastic tissue. We utilized synthetic antisense oligodeoxynucleotides to specifically inhibit N-myc gene expression in the neuroepithelioma cell line CHP100. These cells c...

Journal: :The Journal of biological chemistry 2000
H Liu C R Lo B E Jones Z Pradhan A Srinivasan K L Valentino R J Stockert M J Czaja

The typical proliferative response of hepatocytes to tumor necrosis factor (TNF) can be converted to a cytotoxic one by transcriptional arrest. Although NF-kappaB activation is critical for hepatocyte resistance to TNF toxicity, the contribution of other TNF-inducible transcription factors remains unknown. To determine the function of c-Myc in hepatocyte sensitivity to TNF, stable transfectants...

Journal: :Oncotarget 2016
Qing Ye Zijun Y Xu-Monette Alexandar Tzankov Lijuan Deng Xiaoxiao Wang Ganiraju C Manyam Carlo Visco Santiago Montes-Moreno Li Zhang Karen Dybkær April Chiu Attilio Orazi Youli Zu Govind Bhagat Kristy L Richards Eric D Hsi William W L Choi J Han van Krieken Jooryung Huh Maurilio Ponzoni Andrés J M Ferreri Ben M Parsons Michael B Møller Miguel A Piris Jane N Winter L Jeffrey Medeiros Shimin Hu Ken H Young

Double-hit B-cell lymphoma is a common designation for a group of tumors characterized by concurrent translocations of MYC and BCL2, BCL6, or other genes. The prognosis of concurrent MYC and BCL6 translocations is not well known. In this study, we assessed rearrangements and expression of MYC, BCL2 and BCL6 in 898 patients with de novo diffuse large B-cell lymphoma treated with standard chemoth...

Journal: :Cancer research 2011
Likun Li Chengzhen Ren Guang Yang Elmoataz Abdel Fattah Alexei A Goltsov Soo Mi Kim Ju-Seog Lee Sanghee Park Francesco J Demayo Michael M Ittmann Patricia Troncoso Timothy C Thompson

Downregulation of the proapoptotic p53 target gene glioma pathogenesis-related protein 1 (GLIPR1) occurs frequently in prostate cancer, but the functional meaning of this event is obscure. Here, we report the discovery of functional relationship between GLIPR1 and c-Myc in prostate cancer where c-Myc is often upregulated. We found that the expression of GLIPR1 and c-Myc were inversely correlate...

2017
Philipp Raffeiner Andrea Schraffl Thomas Schwarz Ruth Röck Karin Ledolter Markus Hartl Robert Konrat Eduard Stefan Klaus Bister

The bHLH-LZ (basic region/helix-loop-helix/leucine zipper) oncoprotein Myc and the bHLH-LZ protein Max form a binary transcription factor complex controlling fundamental cellular processes. Deregulated Myc expression leads to neoplastic transformation and is a hallmark of most human cancers. The dynamics of Myc transcription factor activity are post-translationally coordinated by defined protei...

Journal: :Molecular pharmacology 2017
Xiulei Mo Qi Qi Andrei A Ivanov Qiankun Niu Yin Luo Jonathan Havel Russell Goetze Sydney Bell Carlos S Moreno Lee A D Cooper Margaret A Johns Fadlo R Khuri Yuhong Du Haian Fu

The c-Myc (MYC) transcription factor is a major cancer driver and a well-validated therapeutic target. However, directly targeting MYC has been challenging. Thus, identifying proteins that interact with and regulate MYC may provide alternative strategies to inhibit its oncogenic activity. In this study, we report the development of a NanoLuc-based protein-fragment complementation assay (NanoPCA...

Journal: :Cancer research 2007
Geoffrey Bartholomeusz Moshe Talpaz William Bornmann Ling-Yuan Kong Nicholas J Donato

c-Myc is a highly unstable transcription factor whose deregulation and increased expression are associated with cancer. Degrasyn, a small synthetic molecule, induces rapid degradation of c-Myc protein in MM-1 multiple myeloma and other tumor cell lines. Destruction of c-Myc by degrasyn requires the presence of a region of c-Myc between amino acid residues 316 and 378 that has not previously bee...

Journal: :Journal of cell science 2014
Tae-Aug Kim Jin Muk Kang Ja-Shil Hyun Bona Lee Staci Jakyong Kim Eun-Sung Yang Suntaek Hong Ho-Jae Lee Makiko Fujii John E Niederhuber Seong-Jin Kim

In most human cancers the Myc proto-oncogene is highly activated. Dysregulation of Myc oncoprotein contributes to tumorigenesis in numerous tissues and organs. Thus, targeting Myc stability could be a crucial step for cancer therapy. Here we report Smad7 as a key molecule regulating Myc stability and activity by recruiting the F-box protein, Skp2. Ectopic expression of Smad7 downregulated the p...

Journal: :Genes & development 2010
Seung H Choi Jason B Wright Scott A Gerber Michael D Cole

Rapid Myc protein turnover is critical for maintaining basal levels of Myc activity in normal cells and a prompt response to changing growth signals. We characterize a new Myc-interacting factor, TRPC4AP (transient receptor potential cation channel, subfamily C, member 4-associated protein)/TRUSS (tumor necrosis factor receptor-associated ubiquitous scaffolding and signaling protein), which is ...

Journal: :The Journal of biological chemistry 2000
T Brunner S Kasibhatla M J Pinkoski C Frutschi N J Yoo F Echeverri A Mahboubi D R Green

The transcription factor c-Myc is important for the control of cell cycle progression, neoplasia, and apoptotic cell death. c-Myc dimerizes with its partner Max to form an active transcription factor complex. Little is known, however, about the transcriptional targets of c-Myc and their roles in c-Myc-induced cell death. Here we demonstrate that T cell activation-induced expression of Fas ligan...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید